CoreCap Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Sell
24,561
-247
-1% -$19.9K 0.06% 249
2026
Q1
$1.75M Buy
24,808
+418
+2% +$31.3K 0.06% 253
2025
Q4
$1.93M Buy
24,390
+247
+1% +$19.5K 0.07% 247
2025
Q3
$1.99M Sell
24,143
-651
-3% -$51.2K 0.07% 233
2025
Q2
$1.99M Sell
24,794
-30
-0.1% -$2.31K 0.08% 217
2025
Q1
$1.99M Sell
24,824
-236
-0.9% -$19.6K 0.09% 206
2024
Q4
$2.05M Sell
25,060
-1,166
-4% -$97K 0.09% 211
2024
Q3
$2.16M Buy
26,226
+616
+2% +$46K 0.1% 205
2024
Q2
$1.8M Sell
25,610
-311
-1% -$22.2K 0.19% 114
2024
Q1
$1.92M Sell
25,921
-68
-0.3% -$4.74K 0.1% 197
2023
Q4
$1.72M Sell
25,989
-146
-0.6% -$9.14K 0.11% 187
2023
Q3
$1.64M Buy
26,135
+19
+0.1% +$1.18K 0.12% 168
2023
Q2
$1.48M Buy
+26,116
New +$1.45M 0.11% 189
2022
Q4
$1.48M Buy
20,466
+945
+5% +$67.7K 0.11% 182
2022
Q3
$1.19M Buy
19,521
+1,888
+11% +$121K 0.1% 192
2022
Q2
$1.11M Buy
17,633
+1,322
+8% +$87.5K 0.09% 190
2022
Q1
$1.15M Buy
16,311
+1,560
+11% +$105K 0.08% 198
2021
Q4
$922K Buy
+14,751
New +$926K 0.06% 249

Other funds holding MET

CoreCap Advisors's MET Position: Q2 2026 in Review

CoreCap Advisors reduced its MetLife (MET) stake by 1% in Q2 2026, selling an estimated $19.9K and leaving 24,561 shares worth $2.08M. The position accounts for 0.06% of the portfolio, ranked #249.

CoreCap Advisors first reported a position in MET in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.16M in Q3 2024. 338 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • CoreCap Advisors held 24,561 shares of MetLife worth $2.08M as of Q2 2026.
  • CoreCap Advisors sold 247 MetLife shares in Q2 2026, an estimated $19.9K.
  • MetLife made up 0.06% of CoreCap Advisors's portfolio in Q2 2026, its #249 holding.
  • CoreCap Advisors first reported a position in MetLife in Q4 2021 and has held it in 18 quarters since.
  • CoreCap Advisors's MetLife position peaked at $2.16M in Q3 2024.
  • 338 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.